glp-1 patch clinical trial transdermal semaglutide patch Patches: Do They Work? Designing GLP-1 delivery: structural perspectives

Yes by reducing obesity, there is a correlation to the reduction in the prevalence of cardiovascular disease but there is still not enough cost-effectiveness for it to make sense for employers and insurance companies to cover medications like Semaglutide when used for weight-loss purposes

GLP-1 medications work by interacting with specific receptors in the pancreas, digestive system, and brain, helping to increase feelings of fullness, slow gastric emptying, and reduce hunger cravings

Kristiansen, M

PubMed Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response